RET genetic screening in patients with medullary thyroid cancer: The Moroccan experience | Zendy

Abdelhakim Ainahi | Zendy; Barlier Anne | Zendy; Kebbou Mohamed | Zendy; Benabdeljalil Nadia | Zendy; Mohammed Timinouni | Zendy; Taoufiq Fechtali | Zendy; Catherine Roche | Zendy; Saïd El Antri | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

RET genetic screening in patients with medullary thyroid cancer: The Moroccan experience

Author(s) -

Abdelhakim Ainahi,

Barlier Anne,

Kebbou Mohamed,

Benabdeljalil Nadia,

Mohammed Timinouni,

Taoufiq Fechtali,

Catherine Roche,

Saïd El Antri

Publication year - 2009

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.57126

Subject(s) - multiple endocrine neoplasia type 2 , germline mutation , germline , genetics , medullary thyroid cancer , medicine , thyroid carcinoma , mutation , proband , exon , medullary carcinoma , genetic testing , oncology , cancer research , biology , thyroid , gene

Germline RET gene mutations are well known to be the genetic causes of multiple endocrine neoplasia type 2 (MEN2) and may be identified by genetic screening.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research